Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)
Clinical trial NCT01540461 · COMPLETED
Trial details
- NCT number
- NCT01540461
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-11-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.